Last updated on February 2018

Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML


Brief description of study

Assessment of safety and tolerability of drug combination and determine time on treatment, Overall survival (OS) and response rate with patient disease burden, and type of disease

Clinical Study Identifier: NCT02875093

Contact Investigators or Research Sites near you

Start Over

Ta-Chih Liu, MD

Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung, Taiwan
  Connect »

Tsao-Yun Chen, M.D.

National Cheng Kung University Hospital
Tainan, Taiwan
  Connect »

Ming-Chung Kuo, M.D.

Chang Gung Memorial Hospital - Linkou
Taoyuan, Taiwan
  Connect »